Back

Evolving Treatment Landscape for High-Risk HR-Positive/HER2-Negative EBC With and Without gBRCAm

Read this expertguided text module to learn about the evolving treatment landscape for HRpositiveHER2negative early breast cancer including current FDAapproved options guideline recommendations and emerging novel options Dive in to explore key treatment equity considerations for optimizing patient outcomes managing adverse events and promoting adherence

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

IPCE CreditsUp to 0.5 creditsAAPA Category 1 Credit™Up to 0.5 creditsAMA PRA Category 1 Credit™Up to 0.5 creditsNursingUp to 0.5 creditsPharmacyUp to 0.5 credits

MOC types

ABIM — Medical KnowledgeUp to 0.5 points

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • includes Online course / module
  • Credit · Up to 0.5 credits
  • MOC · Up to 0.5 points
  • Commercial Support
  • Released
    May 21, 2026
  • Last day to claim credit
    Nov 21, 2026 6 weeks left